Our mission To use the performance advantage and simplicity of Bimodal Electric Tissue Ablation to transform the radiofrequency ablation market. Our goal is simply To use Bimodal Electric Tissue Ablation to deliver improved outcomes in patients undergoing ablation.
Investors 1
| Date | Name | Website |
| - | Low Carbon... | lcif.vc |
Mentions in press and media 1
| Date | Title | Description | Source |
| 04.10.2017 | 100th deal by Cambridge Capital group | 100th deal by Cambridge Capital group 04-10-2017 Cambridge Capital salutes its members, who have n... | cambridgen... |